Brett Kaplan - 13 Jan 2025 Form 4 Insider Report for Climb Bio, Inc. (CLYM)

Role
Chief Operating Officer
Signature
/s/ Emily Pimblett, as Attorney-in-Fact
Issuer symbol
CLYM
Transactions as of
13 Jan 2025
Net transactions value
$0
Form type
4
Filing time
15 Jan 2025, 16:15:03 UTC
Previous filing
26 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLYM Stock Option (Right to Buy) Award $0 +500,000 $0.000000 500,000 13 Jan 2025 Common Stock 500,000 $1.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 13, 2025 (the "Grant Date"). The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the Grant Date and the remainder are scheduled to vest in 36 equal monthly installments through January 13, 2029, subject to the Reporting Person's continued service.